Page last updated: 2024-10-31

neostigmine and Chronic Idiopathic Intestinal Pseudo-Obstruction

neostigmine has been researched along with Chronic Idiopathic Intestinal Pseudo-Obstruction in 21 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research Excerpts

ExcerptRelevanceReference
"This trial is a randomized, placebo-controlled, double-blinded, mono-centric trial that will test the hypothesis that neostigmine can improve gastrointestinal motility in patients with severe acute pancreatitis."9.69Efficacy and safety of neostigmine on treating gastrointestinal dysmotility in severe acute pancreatitis patients: study protocol for a randomized controlled trial. ( Du, T; Sheng, Y; Sun, H; Zhu, H, 2023)
"We treated a 49-yr-old man with neostigmine, who had liver cirrhosis, acute hepatic encephalopathy, and acute intestinal pseudoobstruction."7.73Neostigmine for the treatment of acute hepatic encephalopathy with acute intestinal pseudo-obstruction in a cirrhotic patient. ( Choi, SK; Joo, YE; Kim, HS; Kim, SJ; Park, CH; Rew, JS, 2005)
"This trial is a randomized, placebo-controlled, double-blinded, mono-centric trial that will test the hypothesis that neostigmine can improve gastrointestinal motility in patients with severe acute pancreatitis."5.69Efficacy and safety of neostigmine on treating gastrointestinal dysmotility in severe acute pancreatitis patients: study protocol for a randomized controlled trial. ( Du, T; Sheng, Y; Sun, H; Zhu, H, 2023)
"The aim of this study was to investigate the efficacy of gastrografin, neostigmine, and their combined administration in patients diagnosed with paralytic ileus in the postoperative period."4.31The efficacy and results of medical treatment in postoperative ileus. ( Alkan, S; Cakir, M; Duyan, AG; Sentiurk, M; Varman, A, 2023)
"We treated a 49-yr-old man with neostigmine, who had liver cirrhosis, acute hepatic encephalopathy, and acute intestinal pseudoobstruction."3.73Neostigmine for the treatment of acute hepatic encephalopathy with acute intestinal pseudo-obstruction in a cirrhotic patient. ( Choi, SK; Joo, YE; Kim, HS; Kim, SJ; Park, CH; Rew, JS, 2005)
"Neostigmine, 0."2.66Neostigmine in postoperative intestinal paralysis. A double-blind, clinical, controlled trial. ( Myrhöj, T; Olsen, O; Wengel, B, 1988)
"Neostigmine has good efficacy in the decompression of pseudo-obstruction but is hindered by its wide side effect profile."1.46Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression. ( Adiamah, A; Ho, A; Johnson, S; Orbell, J, 2017)
"Neostigmine treatment was required for 1 patient in the intensive care unit setting, and 3 patients were managed conservatively without complications."1.46The Potentially Fatal Ogilvie's Syndrome in Lateral Transpsoas Access Surgery: A Multi-Institutional Experience with 2930 Patients. ( Beckman, JM; Januszewski, J; Kanter, AS; Keem, SK; Oskuian, RJ; Smith, W; Taylor, W; Uribe, JS, 2017)
"When peritonitis was achieved, all motor activity ceased in the intracavitary loops and in the isolated loops exposed to acid, so all the intestinal segments were completely paralyzed."1.28[Physiopathology of paralytic ileus secondary to chemical peritonitis. Experimental study in dogs]. ( Canteras Jordana, M; Esteban Redondo, E; García Olmo, D; Hita Villaplana, G; Mompeán Morales, B; Parrilla Paricio, P; Pellicer Franco, E, 1989)

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-199011 (52.38)18.7374
1990's2 (9.52)18.2507
2000's2 (9.52)29.6817
2010's4 (19.05)24.3611
2020's2 (9.52)2.80

Authors

AuthorsStudies
Sun, H1
Sheng, Y1
Du, T1
Zhu, H1
Alkan, S1
Cakir, M1
Sentiurk, M1
Varman, A1
Duyan, AG1
Adiamah, A1
Johnson, S1
Ho, A1
Orbell, J1
Huang, RJ1
Yun, C1
Nguyen, L1
Menys, A1
Butt, S1
Emmanuel, A1
Plumb, AA1
Fikree, A1
Knowles, C1
Atkinson, D1
Zarate, N1
Halligan, S1
Taylor, SA1
Januszewski, J1
Keem, SK1
Smith, W1
Beckman, JM1
Kanter, AS1
Oskuian, RJ1
Taylor, W1
Uribe, JS1
BREINE, U1
HEDENBERG, I1
LILJEDAHL, SO1
HONDA, M1
TAKESHIGE, S1
ISHIKAWA, F1
TOYAMA, F1
KOZMA, JJ1
Park, CH1
Joo, YE1
Kim, HS1
Choi, SK1
Rew, JS1
Kim, SJ1
Weihrauch, TR1
Kilbinger, H1
Herschman, Z1
Borgaonkar, MR1
Lumb, B1
Leonardis, G1
Ciammitti, B1
Splendiani, G1
Champault, G1
Hutchinson, R1
Griffiths, C1
García Olmo, D1
Esteban Redondo, E1
Pellicer Franco, E1
Hita Villaplana, G1
Mompeán Morales, B1
Canteras Jordana, M1
Parrilla Paricio, P1
Myrhöj, T1
Olsen, O1
Wengel, B1
Laustsen, J1
Harling, H1
Fallingborg, J1
Andersen, O1
Lindberg, J1
Modigh, K1
Reske-Nielsen, E1
Staib, I1

Reviews

2 reviews available for neostigmine and Chronic Idiopathic Intestinal Pseudo-Obstruction

ArticleYear
[Motility-effective drugs for therapy of gastrointestinal functional disorders].
    Deutsche medizinische Wochenschrift (1946), 1982, Sep-03, Volume: 107, Issue:35

    Topics: Bethanechol Compounds; Carbachol; Domperidone; Esophagitis, Peptic; Gastrointestinal Diseases; Gastr

1982
Subacute dysautonomia with incomplete recovery.
    Acta neurologica Scandinavica, 1972, Volume: 48, Issue:4

    Topics: Accommodation, Ocular; Acetylcholine; Adie Syndrome; Adult; Biopsy; Carbachol; Cystoscopy; Dexametha

1972

Trials

3 trials available for neostigmine and Chronic Idiopathic Intestinal Pseudo-Obstruction

ArticleYear
Efficacy and safety of neostigmine on treating gastrointestinal dysmotility in severe acute pancreatitis patients: study protocol for a randomized controlled trial.
    Trials, 2023, Feb-06, Volume: 24, Issue:1

    Topics: Acute Disease; Enteral Nutrition; Humans; Infant, Newborn; Intestinal Pseudo-Obstruction; Neostigmin

2023
Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls.
    Neurogastroenterology and motility, 2016, Volume: 28, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Chronic Disease; Cross-Over Studies; Doub

2016
Neostigmine in postoperative intestinal paralysis. A double-blind, clinical, controlled trial.
    Diseases of the colon and rectum, 1988, Volume: 31, Issue:5

    Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Intestinal Pseudo-Obstruction; Neostigmine; P

1988

Other Studies

16 other studies available for neostigmine and Chronic Idiopathic Intestinal Pseudo-Obstruction

ArticleYear
The efficacy and results of medical treatment in postoperative ileus.
    Nigerian journal of clinical practice, 2023, Volume: 26, Issue:4

    Topics: Diatrizoate Meglumine; Humans; Ileus; Intestinal Pseudo-Obstruction; Neostigmine; Postoperative Comp

2023
Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression.
    BMJ case reports, 2017, Sep-11, Volume: 2017

    Topics: Aged, 80 and over; Cecum; Decompression; Diagnosis, Differential; Disease Management; Drug Combinati

2017
Massive gastrointestinal dilatation in a case of hereditary hollow visceral myopathy.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2013, Volume: 45, Issue:10

    Topics: Adult; Cholinesterase Inhibitors; Dilatation, Pathologic; Humans; Intestinal Pseudo-Obstruction; Int

2013
The Potentially Fatal Ogilvie's Syndrome in Lateral Transpsoas Access Surgery: A Multi-Institutional Experience with 2930 Patients.
    World neurosurgery, 2017, Volume: 99

    Topics: Aged; Aged, 80 and over; Cecum; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Human

2017
Treatment of paralytic ileus with cholinesterase inhibitors in intravenous drip.
    Acta chirurgica Scandinavica, 1958, Mar-08, Volume: 114, Issue:3

    Topics: Cholinesterase Inhibitors; Humans; Infusions, Intravenous; Intestinal Obstruction; Intestinal Pseudo

1958
[RADIOLOGICAL STUDIES ON THE RESTORATION OF POSTOPERATIVE PARALYTIC ILEUS AND THE EFFECT OF VARIOUS DRUGS AND MANAGEMENT].
    Rinsho geka. Journal of clinical surgery, 1964, Volume: 19

    Topics: Atropine; Humans; Hypertonic Solutions; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Neost

1964
PARALYTIC ILEUS DUE TO METHOCARBAMOL.
    Clinical medicine (Northfield, Ill.), 1964, Volume: 71

    Topics: Humans; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Methocarbamol; Muscle Cramp; Neostigm

1964
Neostigmine for the treatment of acute hepatic encephalopathy with acute intestinal pseudo-obstruction in a cirrhotic patient.
    Journal of Korean medical science, 2005, Volume: 20, Issue:1

    Topics: Air; Ammonia; Blood Pressure; Cholinesterase Inhibitors; Electrolytes; Enema; Fibrosis; Hepatic Ence

2005
Other ways to stimulate postoperative bowel function.
    Anesthesia and analgesia, 1998, Volume: 87, Issue:2

    Topics: Humans; Intestinal Pseudo-Obstruction; Neostigmine; Postoperative Complications

1998
Acute on chronic intestinal pseudoobstruction responds to neostigmine.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:8

    Topics: Acute Disease; Adult; Amitriptyline; Cholinergic Antagonists; Cholinesterase Inhibitors; Chronic Dis

2000
[Treatment of paralytic ileus using alpha and beta-lytics].
    Bollettino della Societa italiana di biologia sperimentale, 1976, Jul-30, Volume: 52, Issue:14

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Humans; Intestinal Obstruction; Int

1976
[Postoperative ileus. Measurement of the changes in intragastric pressure immediately after abdominal operations (practical deductions)].
    Journal de chirurgie, 1975, Volume: 109, Issue:4

    Topics: Abdomen; Adrenergic beta-Antagonists; Gastrointestinal Motility; Humans; Intestinal Obstruction; Int

1975
Acute colonic pseudo-obstruction: a pharmacological approach.
    Annals of the Royal College of Surgeons of England, 1992, Volume: 74, Issue:5

    Topics: Acute Disease; Aged; Aged, 80 and over; Colonic Diseases; Drug Therapy, Combination; Female; Guaneth

1992
[Physiopathology of paralytic ileus secondary to chemical peritonitis. Experimental study in dogs].
    Revista espanola de las enfermedades del aparato digestivo, 1989, Volume: 76, Issue:4

    Topics: Animals; Cattle; Female; Gastrointestinal Motility; Hydrochloric Acid; Insulin; Intestinal Pseudo-Ob

1989
Treatment of chronic idiopathic intestinal pseudoobstruction.
    Digestive diseases and sciences, 1987, Volume: 32, Issue:2

    Topics: Cholecystokinin; Chronic Disease; Humans; Intestinal Pseudo-Obstruction; Male; Neostigmine; Parasymp

1987
[Therapy of paralytic ileus].
    Minerva medica, 1973, Aug-18, Volume: 64, Issue:58

    Topics: Dehydration; Humans; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Neostigmine; Sodium Chlo

1973